Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: J Biophotonics. 2023 Jun 27;16(10):e202300083. doi: 10.1002/jbio.202300083

Table 2.

Oral hypoglycemic medication used by patients

Class Daily dosage (mg)
Mean ± SD (min-max)
Patients under treatment
# (%)
Biguanides
Metformin 1,605 ± 743 (500–2,550) 10 (100)
Sulfonylureas
Glibenclamide 33 ± 18 (15–50) 2 (20)
Gliclazide 60 ± 0 (NA) 2 (20)
DPP-4 inhibitors
Sitagliptin 100 ± 0 (NA) 1 (10)
SGLT2 inhibitors
Empagliflozin 25 ± 0 (NA) 2 (20)